Search Within

Dmitriy Zamarin

  1. "Radiology, Department of"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (11)
Groups
  1. Department of Medicine (26)
  2. GDMT, Medicine (26)
  3. Gynecologic Medicine Service (26)
  4. Gynecology Disease Management Team (26)
  5. Radiology, Department of (26)
  6. Solid Tumor Oncology Division (26)

More Groups

People
  1. Carol Aghajanian (18)
  2. Roisin O'Cearbhaill (13)
  3. Alexia Iasonos (12)
  4. Qin Zhou (11)
  5. Claire Friedman (9)
  6. Rachel Grisham (9)

More People

Years
  1. 2023 (4)
  2. 2022 (6)
  3. 2021 (2)
  4. 2020 (9)
  5. 2019 (3)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Gynecologic Oncology (5)
  3. Clinical Cancer Research (2)
  4. Gynecologic Oncology Reports (2)
  5. Journal for ImmunoTherapy of Cancer (2)
  6. Cancer Cell (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. Elsevier Inc. (5)
  3. American Association for Cancer Research (2)
  4. Biomed Central Ltd (2)
  5. Elsevier B.V. (2)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PD-1 blockade in advanced adrenocortical carcinoma
    Journal Article

    Raj, N.; Zheng, Y.; Kelly, V.; Katz, S. S.; Chou, J.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Saltz, L. B.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Computed tomography-derived radiomic metrics can identify responders to immunotherapy in ovarian cancer
    Journal Article

    Himoto, Y.; Veeraraghavan, H.; Zheng, J.; Zamarin, D.; Snyder, A.; Capanu, M.; Nougaret, S.; Vargas, H. A.; Shitano, F.; Callahan, M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: Final results
    Meeting Abstract

    Grisham, R.; Giri, D.; Henson, M.; Iasonos, A.; Zhou, Q.; McDonnell, A.; Girshman, J.; O'Cearbhaill, R.; Zamarin, D.; Aghajanian, C.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma
    Meeting Abstract

    Raj, N. P.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J. F.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Ariyan, C. E.; Untch, B. R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission
    Meeting Abstract

    O'Cearbhaill, R. E.; Gnjatic, S.; Aghajanian, C.; Iasonos, A.; Konner, J. A.; Losada, N.; Sarasohn, D.; Rasalan, T.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save